Importantly, in mice transplanted with chemoresistant CD44+ ovarian cancer stem cell xenografts, multiple intraperitoneal treatments with sublethal doses of CPE significantly inhibited ovarian cancer progression (Casagrande et al., 2011). This evidence concerns the gene CD44 and ovarian carcinoma.